Related Experiment Video
Updated: Oct 8, 2025

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Anesthetic Management in Familial Hyperkalemic Periodic Paralysis: A Case Report
Ali Atoot1, Monica Paganessi1, Michael Block1
1Anesthesiology, Hackensack University Medical Center, Hackensack, USA.
Abstract:
Hyperkalemic periodic paralysis (HyperPP) is the rarer of two forms of potassium-associated familial paralysis characterized by episodic flaccid weakness secondary to an increase in serum potassium. The rarest of the dyskalemic paralyzes, the incidence of the hyperkalemic variety has been estimated to be 1:500,000. Known precipitating factors are potassium intake, fasting, hypothermia, infection, stress, rest after exercise, and anesthesia. The key to successful management is avoidance of triggering factors, vigilant monitoring of potassium, and aggressive treatment of hyperkalemia. We present a case of a 41-year-old male with HyperPP who underwent general anesthesia successfully.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Dysrhythmias VI: Management of Dysrhythmias

